211 related articles for article (PubMed ID: 9732201)
1. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.
Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma VM
Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
5. WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer.
Korkolopoulou P; Konstantinidou AE; Thomas-Tsagli E; Christodoulou P; Kapralos P; Davaris P
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):285-92. PubMed ID: 11127920
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas.
Xie X; Clausen OP; Boysen M
Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):897-902. PubMed ID: 12162767
[TBL] [Abstract][Full Text] [Related]
8. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis.
Liu XP; Tsushimi K; Tsushimi M; Kawauchi S; Oga A; Furuya T; Sasaki K
Cancer Lett; 2001 Sep; 170(2):183-9. PubMed ID: 11463497
[TBL] [Abstract][Full Text] [Related]
9. Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor for tumor behavior?
Doganay L; Altaner S; Bilgi S; Kaya E; Ekuklu G; Kutlu K
Int Urol Nephrol; 2003; 35(2):181-8. PubMed ID: 15072490
[TBL] [Abstract][Full Text] [Related]
10. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?
Schwandner O; Bruch HP; Broll R
Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Ala-Opas M; Kosma VM
Prostate; 1999 Apr; 39(1):8-15. PubMed ID: 10221260
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
Wolf HK; Stöber C; Hohenfellner R; Leissner J
Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
Werness BA; Freedman AN; Piver MS; Romero-Gutierrez M; Petrow E
Gynecol Oncol; 1999 Dec; 75(3):413-8. PubMed ID: 10600299
[TBL] [Abstract][Full Text] [Related]
14. Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma.
Clasen S; Schulz WA; Gerharz CD; Grimm MO; Christoph F; Schmitz-Dräger BJ
Br J Cancer; 1998 Feb; 77(4):515-21. PubMed ID: 9484805
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of histopathological grading and immunoreactivity for p53 and p21/WAF1 in grade 2 pTa transitional cell carcinoma of the urinary bladder.
Leissner J; Hohenfellner R; Thüroff JW; Köppen C; Wolf HK
Eur Urol; 2001 Apr; 39(4):438-45. PubMed ID: 11306883
[TBL] [Abstract][Full Text] [Related]
17. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.
Stein JP; Ginsberg DA; Grossfeld GD; Chatterjee SJ; Esrig D; Dickinson MG; Groshen S; Taylor CR; Jones PA; Skinner DG; Cote RJ
J Natl Cancer Inst; 1998 Jul; 90(14):1072-9. PubMed ID: 9672255
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
Lipponen PK; Eskelinen MJ
Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/CIP1) predicts survival and good response to platinin-based chemotherapy.
Costa MJ; Hansen CL; Walls JE; Scudder SA
Hum Pathol; 1999 Jun; 30(6):640-7. PubMed ID: 10374771
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of p21/waf1/cip1 in colorectal cancer.
Zirbes TK; Baldus SE; Moenig SP; Nolden S; Kunze D; Shafizadeh ST; Schneider PM; Thiele J; Hoelscher AH; Dienes HP
Int J Cancer; 2000 Jan; 89(1):14-8. PubMed ID: 10719725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
